Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03745313 · ClinicalTrials.gov registry record · NA
Edwards CLASP TR EFS
A NA study, sponsored by Edwards Lifesciences.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT03745313 is a NA study that has completed, run by Edwards Lifesciences. The registered enrollment target is 65 participants.
The verdict
NCT03745313, a NA study, has completed, sponsored by Edwards Lifesciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
Early feasibility study to assess the safety and performance of the Edwards PASCAL Transcatheter Valve Repair System in tricuspid regurgitation
Interventions
- DEVICE Edwards PASCAL Transcatheter Valve Repair System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2019-02-05 |
| Est. Completion | 2025-05-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03745313
The ClinicalTrials.gov registry entry for NCT03745313 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Edwards PASCAL Transcatheter Valve Repair System is the first listed.
NCT03745313 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03745313 about?
NCT03745313 is a clinical study titled "Edwards CLASP TR EFS". Early feasibility study to assess the safety and performance of the Edwards PASCAL Transcatheter Valve Repair System in tricuspid regurgitation
What is the current status of trial NCT03745313?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2019-02-05. Estimated completion is 2025-05-13.
What interventions are being tested in trial NCT03745313?
The interventions under investigation include: Edwards PASCAL Transcatheter Valve Repair System (DEVICE).
Who is sponsoring clinical trial NCT03745313?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.